NP-34

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameNP-34

Drug Alias Namedual calcium channel blocker/AChE inhibitors (Neuropharma)marine organism extracts (Noscira)calcium channel blockers (Neuropharma)neuroprotectants (Noscira)calcium channel blockers (Noscira) +[7]

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionVoltage-gated calcium channel blockersAcetylcholinesterase inhibitorsNeuroprotectants

TargetsVoltage-gated calcium channelAcetylcholinesterase

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNoscira Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNoscira Sa

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A